Skip to main content

Table 2 Blood analysis during the study

From: Effect of additional treatment with EXenatide in patients with an Acute Myocardial Infarction (EXAMI): study protocol for a randomized controlled trial

Laboratory measurements on admission:

ESR; CRP; hemoglobin; hematocrit; platelet count; leucocytes; leukocyte differential; sodium; potassium; creatinin; urea; AST; ALT; LDH; bilirubin; CK; CK-MB; troponin; total cholesterol; LDL cholesterol; HDL cholesterol; plasma glucose; HbA1c; NT-proBNP; albumin; homocysteine; Lipoproteine(a); Insulin; C-peptide; Free Fatty Acids; APTT; INR;

Routine laboratory measurements (every morning at 9:00)

CRP, hemoglobin; hematocrit; platelet count; leucocytes; sodium; potassium; creatinin; exenatide serum level (during duration of study medication), insulin, C-peptide.

Other laboratory measurements

On the fourth day after admission a triglyceride level and a blood glucose level will be obtained in the fasting state. Exenatide serum levels, insulin and C-peptide will be measured 4 h after initiation of treatment.

Laboratory measurements at follow up visit at 1 month and 4 months

ESR; CRP; hemoglobin; hematocrit; platelet count; leucocytes; sodium; potassium; creatinin; AST; ALT; LDH; total cholesterol; LDL cholesterol; HDL cholesterol; blood glucose level; HbA1c; NT-proBNP; albumine; Lipoproteine (a)